亨斯曼材料 HUN 深沪

等待开盘 02-10 09:30:00 美东时间

13.05

-0.410

-3.05%

华盛通

立即下载

最高13.57
今开13.32
成交量 554.60万股
最低 13.04
昨收 13.46
总市值 22.67亿
52周最高 17.6925
市盈率 ^静 --
换手率 3.19%
52周最低 7.2075
委比 -77.60%
总股本 1.74亿
历史最高 38.0125
量比 0.68
振幅 3.94%
历史最低 -0.3575
每手 1
风险率 2.42%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Stocks Fall, Gold Rallies On Best Day Since 2008: What's Moving Markets Tuesday?

Wall Street extended losses into midday trading Tuesday as geopolitical tensions in the Middle East resurfaced, while gold staged a violent rebound after two days of historic selling.

02-04 02:18
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价

今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元

01-20 10:26
美股大行评级 | 阿斯麦、美光科技、SanDisk获大行上调目标价；美国银行、富国银行绩后遭多家机构下调目标价

今日重点评级关注：Benchmark：维持TNL Mediagene"投机性买入"评级，目标价从3.5美元升至14美元；康托·菲茨杰拉德：维持Eupraxia Pharmaceuticals"超配"评级，目标价从11美元升至19美元

01-16 10:04
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元

今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元

01-13 10:18
UBS Maintains Neutral on Huntsman, Raises Price Target to $12

UBS analyst Joshua Spector maintains Huntsman (NYSE:HUN) with a Neutral and raises the price target from $9 to $12.

01-13 06:13
Huntsman (HUN) Receives a Hold from UBS

In a report released today, Joshua Spector from UBS maintained a Hold rating on...

01-13 02:45
Huntsman Amends Receivables Facility to Enhance Liquidity

Huntsman ( ($HUN) ) just unveiled an announcement. On December 29, 2025, Huntsm...

01-06 06:01
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级

今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元

2025-12-19 10:15
Lux Metals Corp. Announces Strategic Financial Initiatives

Huntsman Exploration ( ($TSE:LXM) ) has shared an update. Lux Metals Corp., a c...

2025-12-12 00:38
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级

今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元

2025-12-05 08:35

派息除权日	每股总股息	派息日期
2025-12-15	0.09	2025-12-31
2025-09-15	0.25	2025-09-30
2025-06-13	0.25	2025-06-30
2025-03-14	0.25	2025-03-31
2024-12-13	0.25	2024-12-31
2024-09-13	0.25	2024-09-30
2024-06-14	0.25	2024-06-28
2024-03-14	0.25	2024-03-29
2023-12-14	0.24	2023-12-29
2023-09-14	0.24	2023-09-29
2023-06-14	0.24	2023-06-30
2023-03-14	0.24	2023-03-31
2022-12-14	0.21	2022-12-30
2022-09-14	0.21	2022-09-30
2022-06-14	0.21	2022-06-30
2022-03-14	0.21	2022-03-31
2021-12-14	0.19	2021-12-31
2021-09-14	0.19	2021-09-30
2021-06-14	0.19	2021-06-30
2021-03-12	0.16	2021-03-31
2020-12-14	0.16	2020-12-31
2020-09-14	0.16	2020-09-30
2020-06-12	0.16	2020-06-30
2020-03-12	0.16	2020-03-31
2019-12-12	0.16	2019-12-31
2019-09-12	0.16	2019-09-30
2019-06-13	0.16	2019-06-28
2019-03-14	0.16	2019-03-29
2018-12-13	0.16	2018-12-31
2018-09-13	0.16	2018-09-28
2018-06-14	0.16	2018-06-29
2018-03-14	0.16	2018-03-30
2017-12-14	0.13	2017-12-29
2017-09-14	0.13	2017-09-29
2017-06-13	0.13	2017-06-30
2017-03-13	0.13	2017-03-31
2016-12-13	0.13	2016-12-30
2016-09-13	0.13	2016-09-30
2016-06-13	0.13	2016-06-30
2016-03-11	0.13	2016-03-31
2015-12-11	0.13	2015-12-31
2015-09-11	0.13	2015-09-30
2015-06-11	0.13	2015-06-30
2015-03-12	0.13	2015-03-31
2014-12-11	0.13	2014-12-31
2014-09-18	0.13	2014-09-30
2014-06-12	0.13	2014-06-30
2014-03-12	0.13	2014-03-31
2013-12-12	0.13	2013-12-31
2013-09-19	0.13	2013-09-30
2013-06-12	0.13	2013-06-28
2013-03-13	0.13	2013-03-29
2012-12-12	0.10	2012-12-31
2012-09-12	0.10	2012-09-28
2012-06-13	0.10	2012-06-29
2012-03-13	0.10	2012-03-30
2011-12-13	0.10	2011-12-30
2011-09-13	0.10	2011-09-30
2011-06-13	0.10	2011-06-30
2011-03-11	0.10	2011-03-31
2010-12-13	0.10	2010-12-31
2010-09-13	0.10	2010-09-30
2010-06-11	0.10	2010-06-30
2010-03-11	0.10	2010-03-31
2009-12-11	0.10	2009-12-31
2009-09-11	0.10	2009-09-30
2009-06-11	0.10	2009-06-30
2009-03-12	0.10	2009-03-31
2008-12-11	0.10	2008-12-31
2008-09-11	0.10	2008-09-30
2008-06-12	0.10	2008-06-30
2008-03-12	0.10	2008-03-31
2007-12-12	0.10	2007-12-31
2007-09-12	0.10	2007-09-28
2007-06-13	0.10	2007-06-29
2007-03-13	0.10	2007-03-30

公司名称	亨斯曼材料
行业分类	化工产品
业务描述	Huntsman Corp. engages in the manufacturing of differentiated organic chemical products. It operates through the following segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment manufactures and markets polyurethane chemicals, including MDI products, PO, polyols, PG, TPU, aniline, and MTBE. The Performance Products segment produces and sells amines, surfactants, LAB, and maleic anhydride to a variety of consumer and industrial end markets. The Advanced Materials segment provides basic liquid and solid epoxy resins, specialty resin compounds, cross linking, matting and curing agents, epoxy, acrylic, and polyurethane based polymer products. The company was founded by Jon Meade Huntsman Sr. in 1970 and is headquartered in The Woodlands, TX.

亨斯曼材料 HUN 深 沪

13.05

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

亨斯曼材料 HUN 深沪